
Sign up to save your podcasts
Or


On this week’s Tech Nation, Moira speaks with Dr. Levi Garraway, the Chief Medical Officer of Genentech about FDA approvals for treatments in two very rare diseases - SMA - Spinal Muscular Atrophy, and NMOSD - Neuromyelitis Optica Spectrum Disorder. Then Dr. Thomas Rando, Co-Founder of Fountain Therapeutics, a Professor at Stanford University School of Medicine, and Director of Glen Laboratories on the Biology of Aging talks about a rampant medical condition – aging.
By Tech Nation4.4
6060 ratings
On this week’s Tech Nation, Moira speaks with Dr. Levi Garraway, the Chief Medical Officer of Genentech about FDA approvals for treatments in two very rare diseases - SMA - Spinal Muscular Atrophy, and NMOSD - Neuromyelitis Optica Spectrum Disorder. Then Dr. Thomas Rando, Co-Founder of Fountain Therapeutics, a Professor at Stanford University School of Medicine, and Director of Glen Laboratories on the Biology of Aging talks about a rampant medical condition – aging.

21,954 Listeners

43,837 Listeners

32,246 Listeners

38,430 Listeners

6,881 Listeners

43,687 Listeners

27,011 Listeners

2,891 Listeners

9,238 Listeners

467 Listeners

736 Listeners

935 Listeners

6,467 Listeners

941 Listeners

33 Listeners